The Pelorus Fund is a cannabis-focused commercial real estate mortgage REIT with a target annualized yield of 15% IRR. The Fund achieved an annualized 15.5% IRR in 2019, and the mortgage REIT qualifies for a 20% federal tax savings with monthly distributions to the Members.
OXIO’s leaders, Noel Guillama, Carl Larsen, and Gregg Steinberg have 90 years of combined experience working around a flawed healthcare system and are on track to delivering the solution as early as year-end 2020.
OXIO is the parent company of five (5) uniquely built, structured companies – all of which are designed to seamlessly work together while reducing cost, empowering patients, enabling providers and advancing the science of healthcare through “technology-infused healthcare.”
OXIO’s leaders Noel Guillama, Carl Larsen, and Gregg Steinberg have 90 years of combined experience working around a flawed healthcare system. Most recently, they have been developing several companies that intrinsically work together to improve patient quality of care, bring financial stability to physicians and advance the science of healthcare through their technology-infused healthcare model. OXIO is already proving their concept in the healthcare space and they will be taking their solution to market in Q3/Q4 2020.